S

Shandong Sinobioway Biomedicine Co Ltd
SZSE:002581

Watchlist Manager
Shandong Sinobioway Biomedicine Co Ltd
SZSE:002581
Watchlist
Price: 11.88 CNY -5.64% Market Closed
Market Cap: 7.8B CNY
Have any thoughts about
Shandong Sinobioway Biomedicine Co Ltd?
Write Note

Shandong Sinobioway Biomedicine Co Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shandong Sinobioway Biomedicine Co Ltd
Interest Income Expense Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
S
Shandong Sinobioway Biomedicine Co Ltd
SZSE:002581
Interest Income Expense
ÂĄ138.3m
CAGR 3-Years
-24%
CAGR 5-Years
-3%
CAGR 10-Years
30%
Fufeng Group Ltd
HKEX:546
Interest Income Expense
ÂĄ241.9m
CAGR 3-Years
79%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
GHW International
HKEX:9933
Interest Income Expense
-ÂĄ37.3m
CAGR 3-Years
-1%
CAGR 5-Years
-28%
CAGR 10-Years
N/A
Ningxia Baofeng Energy Group Co Ltd
SSE:600989
Interest Income Expense
-ÂĄ488.6m
CAGR 3-Years
-12%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
Zhejiang XinAn Chemical Industrial Group Co Ltd
SSE:600596
Interest Income Expense
ÂĄ45.3m
CAGR 3-Years
70%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
Anhui Jinhe Industrial Co Ltd
SZSE:002597
Interest Income Expense
ÂĄ50.9m
CAGR 3-Years
-33%
CAGR 5-Years
4%
CAGR 10-Years
N/A
No Stocks Found

Shandong Sinobioway Biomedicine Co Ltd
Glance View

Market Cap
7.8B CNY
Industry
Chemicals

Shandong Sinobioway Biomedicine Co., Ltd. engages in the research and development, manufacture, and sale of chemical raw materials, chemical and pharmaceutical products. The company is headquartered in Beijing, Beijing and currently employs 653 full-time employees. The company went IPO on 2011-05-20. The firm's main products include encyclopedia, anferon, triethyl orthoformate, trimethyl orthofomate, trimethyl orthoacetate and related secondary products, among others. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
3.08 CNY
Overvaluation 74%
Intrinsic Value
Price
S

See Also

What is Shandong Sinobioway Biomedicine Co Ltd's Interest Income Expense?
Interest Income Expense
138.3m CNY

Based on the financial report for Jun 30, 2024, Shandong Sinobioway Biomedicine Co Ltd's Interest Income Expense amounts to 138.3m CNY.

What is Shandong Sinobioway Biomedicine Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
30%

Over the last year, the Interest Income Expense growth was 3%. The average annual Interest Income Expense growth rates for Shandong Sinobioway Biomedicine Co Ltd have been -24% over the past three years , -3% over the past five years , and 30% over the past ten years .

Back to Top